Benzinga | Feb 24, 2021 04:19PM EST

Aurinia Pharmaceuticals Q4 EPS $(0.05) Beats $(0.14) Estimate, Sales $50.00M Beat $40.00K Estimate

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.14) by 64.29 percent. This is a 82.76 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $50.00 million which beat the analyst consensus estimate of $40.00 thousand by 124.90K percent. This is a 172.31K percent increase over sales of $29.00 thousand the same period last year.